Sex-Specific U-Shaped Relationships Between High-Density Lipoprotein Cholesterol Levels and 10-year Major Adverse Cardiovascular Events: A Nationwide Cohort Study of 5.7 Million South Koreans
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: High-density lipoprotein cholesterol (HDL-C) is a well-known predictor of atherosclerotic cardiovascular diseases (ASCVD). We explored the relationships between HDL-C levels and 10-year major adverse cardiovascular events (MACE) and provided sex-specific upper reference limits for HDL-C levels. Methods: Based on the Korean National Health Insurance Sharing Service, we identified 5,703,897 subjects (women, 48%) with age ≥40 years, eligible HDL-C results, and no prior ASCVD in 2009. We investigated the distribution of 10-year MACE according to HDL-C levels in 10 mg/dL (0.26 mmol/L) intervals and in three HDL-C groups (low: men <40 mg/dL [1.03 mmol/L], women <50 mg/dL [1.29 mmol/L]; high: between low and extremely high levels; and extremely high: >90 mg/dL [2.33 mmol/L]). Results: There were U-shaped relationships between HDL-C levels and 10-year MACE with later inflection in women than in men (nadir: 80-99 mg/dL [2.07-2.56 mmol/L] and 50-59 mg/dL [1.29-1.53 mmol/L], respectively). In men, the extremely high HDL-C group showed significantly higher 10-year MACE than the high group (28.1% vs. 24.6%, P< 0.0001). In women, the extremely high group showed the lowest 10-year MACE; if the extremely high starting point was raised to 130 mg/dL, it became similar to that in men and showed higher 10-year MACE than the high group (25.6% vs. 20.1%, P<0.0001). Conclusions: The 10-year MACE showed U-shaped relationships with HDL-C levels, and extremely high HDL-C level at 90 mg/dL (2.33 mmol/L) in men was corresponding in risk to 130 mg/dL (3.36 mmol/L) in women.
Abstract
Background: High-density lipoprotein cholesterol (HDL-C) is a well-known predictor of atherosclerotic cardiovascular diseases (ASCVD). We explored the relationships between HDL-C levels and 10-year major adverse cardiovascular events (MACE) and provided sex-specific upper reference limits for HDL-C levels. Methods: Based on the Korean National Health Insurance Sharing Service, we identified 5,703,897 subjects (women, 48%) with age ≥40 years, eligible HDL-C results, and no prior ASCVD in 2009. We investigated the distribution of 10-year MACE according to HDL-C levels in 10 mg/dL (0.26 mmol/L) intervals and in three HDL-C groups (low: men <40 mg/dL [1.03 mmol/L], women <50 mg/dL [1.29 mmol/L]; high: between low and extremely high levels; and extremely high: >90 mg/dL [2.33 mmol/L]). Results: There were U-shaped relationships between HDL-C levels and 10-year MACE with later inflection in women than in men (nadir: 80-99 mg/dL [2.07-2.56 mmol/L] and 50-59 mg/dL [1.29-1.53 mmol/L], respectively). In men, the extremely high HDL-C group showed significantly higher 10-year MACE than the high group (28.1% vs. 24.6%, P< 0.0001). In women, the extremely high group showed the lowest 10-year MACE; if the extremely high starting point was raised to 130 mg/dL, it became similar to that in men and showed higher 10-year MACE than the high group (25.6% vs. 20.1%, P<0.0001). Conclusions: The 10-year MACE showed U-shaped relationships with HDL-C levels, and extremely high HDL-C level at 90 mg/dL (2.33 mmol/L) in men was corresponding in risk to 130 mg/dL (3.36 mmol/L) in women.
참고문헌 (34)
- Gordon DJ, "High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies", Circulation, 79, pp.8~15 (1989)
- Emerging Risk Factors Collaboration, "Major lipids, apolipoproteins, and risk of vascular disease", JAMA, 302, pp.1993~2000 (2009)
- Laitinen DL, "Association between HDL-C concentration and risk for a major cardiovascular event", Curr Med Res Opin, 26, pp.933~941 (2010)
- Ahmed HM, "Primary low level of high-density lipoprotein cholesterol and risks of coronary heart disease, cardiovascular disease, and death: results from the Multi-Ethnic Study of Atherosclerosis", Am J Epidemiol, 183, pp.875~883 (2016)
- GoffDC Jr., "2013 ACC", AHA guideline on the assessment of cardiovascular risk : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
- Ko DT, "High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions : the CANHEART study", J Am Coll Cardiol, 68, pp.2073~2083 (2016)
- Madsen CM, "Extreme high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women : two prospective cohort studies", Eur Heart J, 38, pp.2478~2486 (2017)
- Bowe B, "High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. Veterans", Clin J Am Soc Nephrol, 11, pp.1784~1793 (2016)
- Hirata A, "Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study", J Clin Lipidol, 12, pp.674~684 (2018)
- Arnett DK, "2019 ACC", AHA Guideline on the primary prevention of cardiovascular disease : a report of the American College of Cardiology, Circulation, pp.2019, 140[DOI]
- "ACC recommendation"[URL]
- Mach F, "2019 ESC", EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk, 2020, pp.41, 111~188
- Rodriguez A, "High HDL-cholesterol paradox : SCARB1-LAG3-HDL axis", Curr Atheroscler Rep, 23, pp.5~ (2021)
- Grundy SM, "2018 AHA", ACC, AAPA, pp.ABC, ACPM[DOI]
- "Korean standard classification of diseases" (2020)[URL]
- 서미혜, "2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea", Journal of Obesity & Metabolic Syndrome, 28(1), pp.40~45 (2019), 대한비만학회[DOI]
- Heinze G, "Five myths about variable selection", Transpl Int, 30, pp.6~10 (2017)
- Varbo A, "Remnant cholesterol as a causal risk factor for ischemic heart disease", J Am Coll Cardiol, 61, pp.427~436 (2013)
- Wilkins JT, "Coronary heart disease risks associated with high levels of HDL cholesterol", J Am Heart Assoc, 3, pp.e000519~ (2014)
- Tashiro K, "Associations between high levels of high-density lipoprotein cholesterol and the presence and severity of coronary artery disease in patients who have undergone coronary computed tomography angiography", J Clin Med Res, 12, pp.734~739 (2020)
- Oh IH, "Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans", Atherosclerosis, 283, pp.43~51 (2019)
- 양여리, "High-Density Lipoprotein Cholesterol and the Risk of Myocardial Infarction, Stroke, and Cause-Specific Mortality: a Nationwide Cohort Study in Korea", 지질·동맥경화학회지, 10(1), pp.74~87 (2021), 한국지질동맥경화학회[DOI]
- Anagnostis P, "Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions", Maturitas, 81, pp.62~68 (2015)
- Takaeko Y, "Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men", J Clin Lipidol, 13, pp.664~672 (2019)
- Takaeko Y, "Relationship between high-density lipoprotein cholesterol levels and endothelial function in women : a cross-sectional study", BMJ Open, 10, pp.e038121~ (2020)
- Holmes MV, "Mendelian randomization of blood lipids for coronary heart disease", Eur Heart J, 36, pp.539~550 (2015)
- AIM-HIGH Investigators, "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy", N Engl J Med, 365, pp.2255~2267 (2011)
- LincoffAM, "Evacetrapib and cardiovascular outcomes in high-risk vascular disease", N Engl J Med, 376, pp.1933~1942 (2017)
- Tardif JC, "Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes : a randomized trial", Eur Heart J, 35, pp.3277~3286 (2014)
- Zanoni P, "Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease", Science, 351, pp.1166~1171 (2016)
- Agarwala AP, "High-density lipoprotein(HDL)phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease", Arterioscler Thromb Vasc Biol, 35, pp.1515~1519 (2015)
- Madsen CM, "U-shaped relationship of HDL and risk of infectious disease : two prospective population-based cohort studies", Eur Heart J, 39, pp.1181~1190 (2018)
- Royston P, "Dichotomizing continuous predictors in multiple regression : a bad idea", Stat Med, 25, pp.127~141 (2006)
- Hyun Suk Yang, "HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels", Annals of Laboratory Medicine, 40(4), pp.297~305 (2020), 대한진단검사의학회[DOI]